Since the discovery of SCAP, the main goal has been to determine how cholesterol regulates its exit from the ER. A detailed molecular dissection has led to the prediction of an ER anchor for SCAP, which is an integral membrane protein with two major domains ( Figure 1B) . While SCAP's cytoplasmic carboxyl terminus interacts directly with the carboxy-terminal domain of SREBP [5], its amino terminus consists of eight transmembrane domains including a conserved sterol-sensing domain. In humans, four other families of proteins are known to contain sterol-sensing domains, all performing functions related to cholesterol metabolism ( Figure 1B) .
In an elegant set of experiments, also from the Brown and Goldstein group, the SCAP-SREBP complex in fly cells was shown to respond to its major phospholipid, phosphatidylethanolamine (PE) [18] . PE differs from other common phospholipids by its tendency to promote the formation of the inverted hexagonal phase, rather than the lamellar phase, a property also associated with sterols [19] . 
